Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Chemistry & Biology|August 30, 2008
Covalent inhibitors of human monoacylglycerol lipase: ligand-assisted characterization of the catalytic site by mass spectrometry and mutational analysisNikolai Zvonok, Lakshmipathi Pandarinathan, John Williams, et al.
Biochemistry|June 26, 2013
Active-site inhibitors modulate the dynamic properties of human monoacylglycerol lipase: a hydrogen exchange mass spectrometry studyIoannis Karageorgos, Thomas E Wales, David R Janero, et al.
Journal of Proteome Research|May 3, 2008
Full mass spectrometric characterization of human monoacylglycerol lipase generated by large-scale expression and single-step purificationNikolai Zvonok, John Williams, Meghan Johnston, et al.
Bioorganic & Medicinal Chemistry|October 11, 2021
Design, synthesis, and pharmacological profiling of cannabinoid 1 receptor allosteric modulators: Preclinical efficacy of C2-group GAT211 congeners for reducing intraocular pressureSumanta Garai, Peter C Schaffer, Robert B Laprairie, et al.
ACS Chemical Neuroscience|August 4, 2012
Endocannabinoid enzyme engineering: soluble human thio-monoacylglycerol lipase (sol-S-hMGL)Ioannis Karageorgos, Nikolai Zvonok, David R Janero, et al.
ACS Chemical Neuroscience|February 22, 2017
Human Cannabinoid Receptor 2 Ligand-Interaction Motif: Transmembrane Helix 2 Cysteine, C2.59(89), as Determinant of Classical Cannabinoid Agonist Activity and Binding PoseHan Zhou, Yan Peng, Aneetha Halikhedkar, et al.
Free Radical Biology & Medicine|October 11, 2005
Selective nitros(yl)ation induced in vivo by a nitric oxide-donating cyclooxygenase-2 inhibitor: a NObonomic analysisVijay Dhawan, David J Schwalb, Matthew J Shumway, et al.
Clinical Chemistry and Laboratory Medicine|July 10, 2008
Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parametersJodiAnne T Wood, John S Williams, Lakshmipathi Pandarinathan, et al.
Chemistry & Biology|November 22, 2008
Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activationYing Pei, Richard W Mercier, Jenine K Anday, et al.
Journal of Proteome Research|August 25, 2011
Mass spectrometry-based proteomics of human cannabinoid receptor 2: covalent cysteine 6.47(257)-ligand interaction affording megagonist receptor activationDennis W Szymanski, Malvina Papanastasiou, Katja Melchior, et al.
Pageof 7